Journal of Pediatric Surgery
Volume 44, Issue 11 , Pages 2145-2152 , November 2009

Tetrandrine ameliorated reperfusion injury of small bowel transplantation

  • Yun Chen

      Affiliations

    • Department of Surgery, Far Eastern Memorial Hospital, Pan-Chiao, Taipei 220, Taiwan
    • Department of Chemical Engineering and Materials Science, Yuan Ze University, Chung-Li, Taoyuan 320, Taiwan
    • ,
  • Jiann-Ming Wu

      Affiliations

    • Department of Surgery, Far Eastern Memorial Hospital, Pan-Chiao, Taipei 220, Taiwan
    • ,
  • Tzu-Yu Lin

      Affiliations

    • Department of Anesthesiology, Far Eastern Memorial Hospital, Pan-Chiao, Taipei 220, Taiwan
    • Department of Mechanical Engineering, Yuan Ze University, Chung-Li, Taoyuan 320, Taiwan
    • ,
  • Chia-Chan Wu

      Affiliations

    • Department of Anesthesiology, Far Eastern Memorial Hospital, Pan-Chiao, Taipei 220, Taiwan
    • ,
  • Kuan-Ming Chiu

      Affiliations

    • Center of Cardiovascular, Far Eastern Memorial Hospital, Pan-Chiao, Taipei 220, Taiwan
    • ,
  • Bee-Feng Chang

      Affiliations

    • Department of Pediatrics, Far Eastern Memorial Hospital, Pan-Chiao, Taipei 220, Taiwan
    • ,
  • Sheng-Hong Tseng

      Affiliations

    • Department of Chemical Engineering and Materials Science, Yuan Ze University, Chung-Li, Taoyuan 320, Taiwan
    • Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei 100, Taiwan
    • Corresponding Author InformationCorresponding author. Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei 100, Taiwan. Tel.: +886 2 23123456x65110; fax: +886 2 89665567.
    • ,
  • Shu-Hsun Chu

      Affiliations

    • Center of Cardiovascular, Far Eastern Memorial Hospital, Pan-Chiao, Taipei 220, Taiwan

Received 8 March 2009 ,Revised 29 May 2009 ,Accepted 1 June 2009.

References 

  1. Chan KL, Chan CW, Tam PKH. Segmental small bowel allograft-ischemic injury and regeneration. J Pediatr Surg. 1998;33:1703–1706
  2. Ho LJ, Chang DM, Chang ML, et al. Mechanism of immunosuppression of the antirheumatic herb TWHf in human T cells. J Rheumatol. 1999;26:14–22
  3. Kondo Y, Takano F, Hojo H. Suppression of lipopolysaccharide-induced fulminant hepatitis and tumor necrosis factor production by bis-benzylisoquinoline alkaloids in bacillus Calmette-Guerin-treated mice. Biochem Pharmacol. 1993;46:1861–1863
  4. Lee SH, Nan JX, Sohn DH. Tetrandrine prevents tissue inhibitor of metalloproteinase-1 messenger RNA expression in rat liver fibrosis. Pharmacol Toxicol. 2001;89:214–216
  5. Lin TY, Tseng SH, Lin SJ, et al. Tetrandrine increased the survival rate of mice with lipopolysaccharide-induced endotoxemia. J Trauma. 2009;66:411–417
  6. Liu BC, He YX, Miao Q, et al. The effect of tetrandrine and polyvinylpyridine-N-oxide (PVNO) on gene expression of type I and III collagens during experimental silicosis. Biomed Environ Sci. 1994;7:199–204
  7. Xiao J, Wu S, Wang Y, et al. Inhibitory effects of tetrandrine on bovine serum albumin-induced uveitis in rabbits. J Ocular Pharmacol. 1993;9:151–156
  8. Wang G, Lemos JR, Iadecola C. Herbal alkaloid tetrandrine: from an ion channel blocker to inhibitor of tumor proliferation. Trends Pharmacol Sci. 2004;25:120–123
  9. Huang YT, Cheng YR, Lin HC, et al. Haemodynamic effects of chronic tetrandrine treatment in portal hypertensive rats. J Gastroenterol Hepatol. 1997;12:585–589
  10. Lieberman I, Lentz DP, Trucco GA, et al. Prevention by tetrandrine of spontaneous development of diabetes mellitus in BB rats. Diabetes. 1992;41:616–619
  11. Shen YC, Chen CF, Sung YJ. Tetrandrine ameliorates ischaemia-reperfusion injury of rat myocardium through inhibition of neutrophil priming and activation. Br J Pharmacol. 1999;128:1593–1601
  12. Wang HL, Kilfeather SA, Martin GR, et al. Effects of tetrandrine on growth factor-induced DNA synthesis and proliferative response of rat pulmonary artery smooth muscle cells. Pulm Pharmacol Ther. 2000;13:53–60
  13. Chen Y, Chen JC, Tseng SH. Tetrandrine suppresses tumor growth and angiogenesis of gliomas in rats. Int J Cancer. 2009;124:2260–2269
  14. Jang BC, Lim KJ, Paik JH, et al. Tetrandrine-induced apoptosis is mediated by activation of caspases and PKC-δ in U937 cells. Biochem Pharmacol. 2004;67:1819–1829
  15. Ng LT. Antiproliferative and apoptotic effects of tetrandrine on different human hepatoma cell lines. Am J Chin Med. 2006;34:125–135
  16. Hui SCG, Chan TY, Chen YY. Tetrandrine inhibits lipid peroxidation but lacks reactivity towards superoxide anion and hydrogen peroxide. Pharmacol Toxicol. 1996;78:200–201
  17. Koh SB, Ban JY, Lee BY, et al. Protective effects of fangchinoline and tetrandrine on hydrogen peroxide-induced oxidative neuronal cell damage in cultured rat cerebellar granule cells. Planta Med. 2003;69:506–512
  18. Liu SJ, Zhou SW, Xue CS. Effect of tetrandrine on neutrophilic recruitment response to brain ischemia/reperfusion. Acta Pharmacol Sin. 2001;22:971–975
  19. Liu Z, Xu Z, Shen W, et al. Effect of pharmacologic preconditioning with tetrandrine on subsequent ischemia/reperfusion injury in rat liver. World J Surg. 2004;28:620–624
  20. Nadalin S, Biglania AR, Testa G, et al. Role and significance of plasma citrulline in the early phase after small bowel transplantation in pigs. Transplant Int. 2007;20:425–431
  21. Herman EH, Chadwick DP. Cardiovascular effects of d-Tetrandrine. Pharmacology. 1974;12:97–109
  22. Zeng FD, Shaw DH, Ogilvie RI. Kinetic disposition and hemodynamic effects of tetrandrine in anesthesized dogs. J Cardiovasc Pharmacol. 1985;7:1034–1039
  23. Chiu CJ, McArdle AH, Brown R, et al. Intestinal mucosal lesion in low-flow states. I. A morphological hemodynamic, and metabolic reappraisal. Arch Surg. 1970;101:478–483
  24. Pascher A, Klupp J. Biologics in the treatment of transplant rejection and ischemia/reperfusion injury. Biodrugs. 2005;19:211–231
  25. Laskowski I, Pratschke J, Wilhelm MJ, et al. Molecular and cellular events associated with ischemia/reperfusion injury. Ann Transplant. 2000;5:29–35
  26. Mallick IH, Yang W, Winslet MC, et al. Ischemia-reperfusion injury of the intestine and protective strategies against injury. Digest Dis Sci. 2004;49:1359–1377
  27. Massberg S, Gonzalez AP, Leiderer R, et al. In vivo assessment of the influence of cold preservation time on microvascular reperfusion injury after experimental small bowel transplantation. Br J Surg. 1998;85:127–133
  28. Lee JC, Latdon JT, McDonnell PC, et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 1994;372:739–746
  29. Farmer DG, McDiarmid SV, Kuniyoshi J, et al. Intragraft expression of messenger RNA for interleukin-6 and tumor necrosis-α is a predictor of rat small intestine transplant rejection. J Surg Res. 1994;57:138–142
  30. Frangogiannis NG. Targeting the inflammatory response in healing myocardial infarcts. Curr Med Chem. 2006;13:1877–1893
  31. Farmer DG, Shen XD, Amersi F, et al. CD62 blockade with P-selectin glycoprotein ligand-immunoglobulin fusion protein reduces ischemia-reperfusion injury after rat intestinal transplantation. Transplantation. 2005;79:44–51
  32. Sisley AC, Desai T, Harig JM, et al. Neutrophil depletion attenuates human intestinal reperfusion injury. J Surg Res. 1994;57:192–196
  33. Hansen PR. Role of neutrophils in myocardial ischemia and reperfusion. Circulation. 1995;91:1872–1885

☆ This study was supported by research grants (FEMH-94-C-015 from Far Eastern Memorial Hospital and NSC95-2314-B-418-005 from the National Science Council, Taiwan, ROC) awarded to Dr Yun Chen.

PII: S0022-3468(09)00457-6

doi: 10.1016/j.jpedsurg.2009.06.002

Journal of Pediatric Surgery
Volume 44, Issue 11 , Pages 2145-2152 , November 2009

Article Tools

* Image Usage & Resolution